Source: finance.yahoo.com

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

President & CEO

David Guyer

CEO Approval Rating

90/100

EyeBio is an England-based ophthalmology biotech company that researches and develops novel therapies for the treatment of eye diseases.

Eyebio Was acquired by Merck & Co., Inc. for $3B